Download PDF

Other users also viewed these articles

Examining the prevalence of hepatic steatosis and advanced fibrosis using non-invasive measures across Canada: A national estimate using the Canadian Health Measures Survey (CHMS) from 2009-2019 Jacob Romano; Jessica Burnside; Giada Sebastiani; Alnoor Ramji; Keyur Patel; Mark Swain; Sahar Saeed;
10.1016/j.aohep.2024.101757
Blood pressure stratification for predicting liver fibrosis risk in metabolic dysfunction associated fatty liver disease Jing Liu; Haifeng Lv; Jie Wang; Qianru Zhu; Gongying Chen; Yanming Jiang; Ke Zhao; Li Shao; Junping Shi; Xiaoben Pan;
Ann Hepatol. 2023;28:
Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver disease Shan Hong; Yiwei Hao; Lei Sun; Ping Li; Junru Yang; Fuyang Zhang; Lingling He; Jing Zhang; Hongshan Wei;
10.1016/j.aohep.2024.101589